Gene · 4929
Papers4,115
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 4,115
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of LncRNAs and microRNAs in neuronal development and disease. | PeerJ | 2023 | 37038472 | PubTator, text mining | PubMed |
| Regulation of immune responses in primary biliary cholangitis: a transcriptomic analysis of peripheral immune cells. | Hepatol Commun | 2023 | 37026715 | PubTator, text mining | PubMed |
| Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction. | Nat Commun | 2023 | 37024479 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Genome-wide DNA methylation analysis in families with multiple individuals diagnosed with schizophrenia and intellectual disability. | World J Biol Psychiatry | 2023 | 37017099 | PubTator, text mining | PubMed |
| ATG8-dependent LMX1B-autophagy crosstalk shapes human midbrain dopaminergic neuronal resilience. | J Cell Biol | 2023 | 37014324 | PubTator, text mining | PubMed |
| Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T Cell-Intrinsic Dysfunction. | Cancer Discov | 2023 | 37011008 | PubTator, text mining | PubMed |
| First-in-human clinical trial of the NKT cell-stimulatory glycolipid OCH in multiple sclerosis. | Ther Adv Neurol Disord | 2023 | 36993937 | PubTator, text mining | PubMed |
| Tumor Suppressor Role of INPP4B in Chemoresistant Retinoblastoma. | J Oncol | 2023 | 36993823 | PubTator, text mining | PubMed |
| Machine learning-based predictive models and drug prediction for schizophrenia in multiple programmed cell death patterns. | Front Mol Neurosci | 2023 | 36993785 | PubTator, text mining | PubMed |
| Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson's Disease. | Pharmaceutics | 2023 | 36986700 | PubTator, text mining | PubMed |
| Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1. | Int J Mol Sci | 2023 | 36982850 | PubTator, text mining | PubMed |
| The Influence of Prenatal Exposure to Methamphetamine on the Development of Dopaminergic Neurons in the Ventral Midbrain. | Int J Mol Sci | 2023 | 36982742 | PubTator, text mining | PubMed |
| Zeb2 DNA-Binding Sites in Neuroprogenitor Cells Reveal Autoregulation and Affirm Neurodevelopmental Defects, Including in Mowat-Wilson Syndrome. | Genes (Basel) | 2023 | 36980900 | PubTator, text mining | PubMed |
| Evaluation of Genetic Testing in a Cohort of Diverse Pediatric Patients in the United States with Congenital Cataracts. | Genes (Basel) | 2023 | 36980880 | PubTator, text mining | PubMed |
| Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives. | Cancers (Basel) | 2023 | 36980713 | PubTator, text mining | PubMed |
| Pathogenic Microglia Orchestrate Neurotoxic Properties of Eomes-Expressing Helper T Cells. | Cells | 2023 | 36980209 | PubTator, text mining | PubMed |
| Potential Biomarkers and Endometrial Immune Microenvironment in Recurrent Implantation Failure. | Biomolecules | 2023 | 36979341 | PubTator, text mining | PubMed |
| Somatic Cell Reprogramming for Nervous System Diseases: Techniques, Mechanisms, Potential Applications, and Challenges. | Brain Sci | 2023 | 36979334 | PubTator, text mining | PubMed |
| Characterization by Gene Expression Analysis of Two Groups of Dopaminergic Cells Isolated from the Mouse Olfactory Bulb. | Biology (Basel) | 2023 | 36979058 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4929/papers?page=23